The value of 18F-FDG-PET/CT imaging in oral cavity cancer patients following surgical reconstruction

Laryngoscope

Volumn 125, Issue 8, 2015, Pages 1861-1868

  Müller, Julian ^a   Hüllner, Martin ^a,b   Strobel, Klaus ^d   Huber, Gerhard F ^c   Burger, Irene A ^a   Haerle, Stephan K ^e  

^a Division of Nuclear Medicine   (United States)

^b Department of Medical Radiology Clinic of Neuroradiology   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d LUZERNER KANTONSSPITAL   (Switzerland)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

18F FDG PET CT; flap; follow up; head and neck cancer; oral cavity; reconstruction

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SCINTISCANNING; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER SYSTEM; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISTANT METASTASIS; DRUG UPTAKE; FEMALE; FOLLOW UP; FREE TISSUE GRAFT; HUMAN; LOW DRUG DOSE; LYMPH NODE METASTASIS; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MOUTH SQUAMOUS CELL CARCINOMA; ORAL SURGERY; PEDICLED SKIN FLAP; PET-CT SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; WHOLE BODY CT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; EAR NOSE THROAT SURGERY; MOUTH NEOPLASMS; MULTIMODAL IMAGING; NEOPLASM RECURRENCE, LOCAL; PLASTIC SURGERY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PROCEDURES; SECONDARY; SURGICAL FLAPS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIMODAL IMAGING; NEOPLASM RECURRENCE, LOCAL; OTORHINOLARYNGOLOGIC SURGICAL PROCEDURES; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; RADIOPHARMACEUTICALS; RECONSTRUCTIVE SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; ROC CURVE; SURGICAL FLAPS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84937522914     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.25326     Document Type: Article

References (26)

1. Schelstraete K, Simons M, Deman J, et al., Uptake of 13N-ammonia by human tumours as studied by positron emission tomography. Br J Radiol 1982; 55: 797-804.
2. Beyer T, Townsend DW, Brun T, et al., A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41: 1369-1379.
3. Branstetter BF 4th, Blodgett TM, Zimmer LA, et al., Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 2005; 235: 580-586.
4. Johnson JT, Branstetter BF 4th,. PET/CT in head and neck oncology: state-of-the-art 2013. Laryngoscope 2014; 124: 913-915.
5. Strobel K, Haerle SK, Stoeckli SJ, et al., Head and neck squamous cell carcinoma (HNSCC)-detection of synchronous primaries with (18)F-FDG-PET/CT. Eur J Nucl Med Mol Imaging 2009; 36: 919-927.
6. Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli SJ,. (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma. Head Neck 2010; 32: 319-325.
7. Haerle SK, Schmid DT, Ahmad N, Hany TF, Stoeckli SJ,. The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma. Oral Oncol 2011; 47: 653-659.
8. Ong SC, Schoder H, Lee NY, et al., Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer. J Nucl Med 2008; 49: 532-540.
9. Schoder H, Fury M, Lee N, Kraus D,. PET monitoring of therapy response in head and neck squamous cell carcinoma. J Nucl Med 2009; 50 (suppl 1): 74S-88S.
10. Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM,. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004; 231: 65-72.
11. Haerle SK, Hany TF, Ahmad N, Burger I, Huber GF, Schmid DT,. Physiologic [18F]fluorodeoxyglucose uptake of floor of mouth muscles in PET/CT imaging: a problem of body position during FDG uptake? Cancer Imaging 2013; 13: 1-7.
12. Som PM,. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. AJR Am J Roentgenol 1992; 158: 961-969.
13. Krabbe CA, Pruim J, Dijkstra PU, et al., 18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study. J Nucl Med 2009; 50: 1940-1947.
14. Lapela M, Eigtved A, Jyrkkio S, et al., Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer 2000; 36: 858-867.
15. Chen AY, Vilaseca I, Hudgins PA, Schuster D, Halkar R,. PET-CT vs contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer? Head Neck 2006; 28: 487-495.
16. Rangaswamy B, Fardanesh MR, Genden EM, et al., Improvement in the detection of locoregional recurrence in head and neck malignancies: F-18 fluorodeoxyglucose-positron emission tomography/computed tomography compared to high-resolution contrast-enhanced computed tomography and endoscopic examination. Laryngoscope 2013; 123: 2664-2669.
17. Abgral R, Querellou S, Potard G, et al., Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up? J Nucl Med 2009; 50: 24-29.
18. Laffon E, Lamare F, de Clermont H, Burger IA, Marthan R,. Variability of average SUV from several hottest voxels is lower than that of SUVmax and SUVpeak. Eur Radiol 2014; 24: 1964-1970.
19. Makris NE, Huisman MC, Kinahan PE, Lammertsma AA, Boellaard R,. Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures. Eur J Nucl Med Mol Imaging 2013; 40: 1507-1515.
20. Kunkel M, Wahlmann U, Grotz KA, et al., [Value of (F18)-2-fluorodeoxyglucose PET scanning in staging mouth cavity carcinoma. Comparative evaluation of PET findings before and after preoperative radiochemotherapy with histological and computerized tomography findings]. Mund Kiefer Gesichtschir 1998; 2: 181-187.
21. Dunsky KA, Wehrmann DJ, Osman MM, Thornberry BM, Varvares MA,. PET-CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient. Laryngoscope 2013; 123: 2161-2164.
22. Veit-Haibach P, Kuhn FP, Wiesinger F, Delso G, von Schulthess G,. PET-MR imaging using a tri-modality PET/CT-MR system with a dedicated shuttle in clinical routine. MAGMA 2013; 26: 25-35.
23. Drzezga A, Souvatzoglou M, Eiber M, et al., First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med 2012; 53: 845-855.
24. Kubiessa K, Purz S, Gawlitza M, et al., Initial clinical results of simultaneous 18F-FDG PET/MRI in comparison to 18F-FDG PET/CT in patients with head and neck cancer. Eur J Nucl Med Mol Imaging 2014; 41: 639-648.
25. Queiroz M, Hullner M, Kuhn F, et al., PET/MRI and PET/CT in follow-up of head and neck cancer patients. Eur J Nucl Med Mol Imaging 2014; 41: 1066-1075.
26. Kuhn FP, Hullner M, Mader CE, et al., Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed? J Nucl Med 2014; 55: 551-558.